#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    B-cell small lymphocytic lymphoma refractory Follicle centre lymphoma follicular grade I II – III refractory Demyelination Antithrombin III deficiency Krabbe's disease Narcolepsy Epilepsy with myoclonic-atonic seizures Juvenile idiopathic arthritis Myxofibrosarcoma Chondrosarcoma metastatic Arrhythmia Ornithine transcarbamoylase deficiency Adrenoleukodystrophy Epstein-Barr virus associated lymphoproliferative disorder Pelizaeus-Merzbacher disease More trials…

    Learn about Rare Diseases

    Aicardi-Goutieres syndrome – Diagnostics Chondrosarcoma metastatic – Treatment Congenital hypotransferrinaemia Indolent systemic mastocytosis – Diagnostics Factor IX deficiency – Trials in Disease Paroxysmal nocturnal haemoglobinuria – Life with Disease Hypereosinophilic syndrome – Trials in Disease Myelodysplastic syndrome Leiomyosarcoma metastatic – Trials in Disease Wolfram syndrome – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Msv-Allo Tetracycline Hydrochloride Sapropterin Dihydrochloride [14C] DC-806 F510/08 Budesonide Bleomycin Tinengotinib Messenger Rna Encoding Cas9 Bcmacp03 Histamine Dihydrochloride Burfiralimab Oxcarbazepine Solrikitug Emrusolmin Galcanezumab Dazodalibep Eik1003 CICLOPIROX Opium, Standardized Powdered More therapies…

    Learn about Your Condition

    Kearns-Sayre syndrome Systemic infection Postpartum haemorrhage Iron deficiency Post procedural swelling Intestinal ischaemia Ischaemic stroke Post procedural hypotension Endocarditis bacterial Tumour thrombosis Barrett's oesophagus Asthmatic crisis Adrenal insufficiency Vulval cancer Microvillous inclusion disease More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Intranasal Dexmedetomidine for Pain Relief During Retinopathy of Prematurity Screening in Preterm Infants <30 Weeks Gestation Using Standard Drug Combination

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Retinopathy of prematurity
    Investigated Drugs:
    • Phenylephrine Hydrochloride
    • Oxybuprocaine Hydrochloride
    • Dexmedetomidine
    Norway

  • Feasibility and Safety of PEX010 Psilocybin Capsules (5 mg and 25 mg) in Military Veterans with Posttraumatic Stress Disorder

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Post-traumatic stress disorder
    Investigated Drugs:
    • Dry Extract From Psilocybe Cubensis (15-25:1), Extraction Solvent: Methanol
    The Netherlands

  • Effect of dapagliflozin and semaglutide on heart insulin resistance in type 2 diabetes patients

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • Dapagliflozin Propanediol
    • Semaglutide
    Spain

  • Study of CC-97540 (CD19‑Targeted NEX‑T CAR T) versus drug combination in adults with active systemic sclerosis

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Nintedanib
    • CC-97540
    • Fludarabine Phosphate
    Belgium France Germany Italy Spain

  • Safety and efficacy of stopping versus maintenance dose of filgotinib, tofacitinib and upadacitinib in adult ulcerative colitis patients in deep remission

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • Filgotinib
    • Tofacitinib
    • Upadacitinib
    France

  • Efficacy of intravenous prasinezumab versus placebo in Parkinson’s disease patients with severe GBA mutation: a 104‑week randomized double‑blind study

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Parkinson’s disease
    Investigated Drugs:
    • Prasinezumab
    • Sodium Chloride
    France Germany Italy Luxembourg Spain Sweden
Previous Page
1 … 692 693 694 695 696 … 1,656
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!